View Archive »
About The Cover
The cover for issue 37 of Oncotarget features Figure 5, "Synergy between ibrutinib or idelalisib and CSF1R inhibitors in majority of CLL patient specimens," from Edwards, et al.
|
|
Table of Contents
Editorial: Autophagy and Cell Death
|
| The p53p21 pathway inhibits ferroptosis during metabolic stress |
|
https://doi.org/10.18632/oncotarget.25362
|
| 24572-24573 |
|
| Aspirin induces autophagy via inhibition of the acetyltransferase EP300 |
|
https://doi.org/10.18632/oncotarget.25364
|
| 24574-24575 |
Priority Research Papers
|
| Targeting of colonystimulating factor 1 receptor CSF1R in the CLL microenvironment yields antineoplastic activity in primary patient samples |
|
https://doi.org/10.18632/oncotarget.25191
|
| 24576-24589 |
Research Papers: Gerotarget (Focus on Aging)
|
| Genomewide significant risk factors on chromosome 19 and the APOE locus |
|
https://doi.org/10.18632/oncotarget.25083
|
| 24590-24600 |
Research Papers
|
| Olmesartan attenuates pressureoverload or postinfarctioninduced cardiac remodeling in mice |
|
https://doi.org/10.18632/oncotarget.23628
|
| 24601-24618 |
|
| Evaluation of liver fibrosis with a monoexponential model of intravoxel incoherent motion magnetic resonance imaging |
|
https://doi.org/10.18632/oncotarget.24758
|
| 24619-24626 |
|
| Androgeninduced alterations in endometrial proteins crucial in recurrent miscarriages |
|
https://doi.org/10.18632/oncotarget.24821
|
| 24627-24641 |
|
| Premorbid BMI as a prognostic factor in smallcell lung cancer—a single institute experience |
|
https://doi.org/10.18632/oncotarget.24935
|
| 24642-24652 |
|
| Collagen type 1 promotes survival of human breast cancer cells by overexpressing Kv101 potassium and Orai1 calcium channels through DDR1dependent pathway |
|
https://doi.org/10.18632/oncotarget.19065
|
| 24653-24671 |
|
| Stability and antitumor effect of oncolytic herpes simplex virus type 2 |
|
https://doi.org/10.18632/oncotarget.25122
|
| 24672-24683 |
|
| An integromic signature for lung cancer early detection |
|
https://doi.org/10.18632/oncotarget.25227
|
| 24684-24692 |
|
| Potentiation of 177Luoctreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor |
|
https://doi.org/10.18632/oncotarget.25266
|
| 24693-24706 |
|
| Platinum sensitivity and DNA repair in a recently established panel of patientderived ovarian carcinoma xenografts |
|
https://doi.org/10.18632/oncotarget.25185
|
| 24707-24717 |
|
| Regulatory role of resveratrol a microRNAcontrolling compound in HNRNPA1 expression which is associated with poor prognosis in breast cancer |
|
https://doi.org/10.18632/oncotarget.25339
|
| 24718-24730 |
|
| Cirmtuzumab inhibits ibrutinibresistant Wnt5ainduced Rac1 activation and proliferation in mantle cell lymphoma |
|
https://doi.org/10.18632/oncotarget.25340
|
| 24731-24736 |
|
| 89Zrlabeled CEAtargeted IL2 variant immunocytokine in patients with solid tumors: CEAmediated tumor accumulation and role of IL2 receptorbinding |
|
https://doi.org/10.18632/oncotarget.25343
|
| 24737-24749 |
|
| Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma |
|
https://doi.org/10.18632/oncotarget.25345
|
| 24750-24765 |
|
| Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cellcell communication mechanisms |
|
https://doi.org/10.18632/oncotarget.25346
|
| 24766-24777 |
|
| Expression of PREX2a is associated with poor prognosis in endometrial malignancies |
|
https://doi.org/10.18632/oncotarget.25349
|
| 24778-24786 |
|
| Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patientderived xenograft model of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.25361
|
| 24787-24800 |
|
| Prognostic significance of immune cells in nonsmall cell lung cancer: metaanalysis |
|
https://doi.org/10.18632/oncotarget.24835
|
| 24801-24820 |
|
| Prognostic value of Midkine expression in patients with solid tumors: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.23892
|
| 24821-24829 |
Clinical Research Papers
|
| A quality analysis of clinical anaesthesia study protocols from the Chinese clinical trials registry according to the SPIRIT statement |
|
https://doi.org/10.18632/oncotarget.24982
|
| 24830-24836 |
Reviews
|
| Bglucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine |
|
https://doi.org/10.18632/oncotarget.24984
|
| 24837-24856 |
|
| Association of PDCD6 polymorphisms with the risk of cancer: Evidence from a metaanalysis |
|
https://doi.org/10.18632/oncotarget.25324
|
| 24857-24868 |
Corrections
|
| Correction: Molecular crosstalk between ferroptosis and apoptosis: Emerging role of ER stressinduced p53independent PUMA expression |
|
https://doi.org/10.18632/oncotarget.25365
|
| 24869-24869 |
|
| Correction: Berberinetargeted miR21 chemosensitizes oral carcinomas stem cells |
|
https://doi.org/10.18632/oncotarget.25460
|
| 24870-24870 |
|
| Correction: MiR124 acts as a target for Alzheimer’s disease by regulating BACE1 |
|
https://doi.org/10.18632/oncotarget.25461
|
| 24871-24871 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
